
|Articles|February 2, 2002
FDA gives nod to etanercept for psoriatic arthritis Tx
Seattle - Already approved for the treatment of rheumatoid arthritis,the FDA granted approval that extends etanercept's (Enbrel) use to the treatmentof psoriatic arthritis for the one million American sufferers.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
2
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
3
Introducing Dermatology Times NP/PA Connect
4
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
5











